Clinical trial
Latrunculin A Supplementation to ICSI Handling Medium
NCT03678818 is registered in ClinicalTrials.gov with Ibn Sina Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Latrunculin A Supplementation to ICSI Handling Medium
- Lead sponsor
- Ibn Sina Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 25, 2018
- Completion date
- April 30, 2019
- Enrollment
- 300 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.